Subsequently, we and others reported a number of de novo SCN2A mutations in patients with neurological disorders such as epileptic encephalopathy including Ohtahara syndrome, West syndrome, Lennox Gastaut syndrome5–9, ASD10,11, intellectual disability12,13, and schizophrenia14,15. The gene discussed is SCN2A; the disease is early-infantile DEE.